Caring Brands, Inc. (CABR) 株式分析

企業概要

Caring Brands, Inc. is a wellness consumer products company that provides over-the-counter and cosmetic consumer products designed to address specific dermatological and cosmetic needs. The enterprise operates within the broader Healthcare sector, specifically classified under the industry of Drug Manufacturers - Specialty & Generic, which implies a focus on developing and distributing specialized pharmaceutical or non-pharmaceutical therapeutic agents. The company's market capitalization stands at $17.24M, while its annual revenue for the trailing twelve months is reported at $4,215, with employee count data listed as N/A. These valuation and revenue figures indicate that Caring Brands, Inc. is a micro-cap entity with a very limited market presence and negligible revenue scale relative to established industry peers. The minimal revenue base combined with a small market cap suggests the company is in a highly constrained operational phase, likely prioritizing product development or market entry rather than established market dominance. The absence of publicly disclosed employee data further underscores the nascent nature of the organization's human capital structure within the competitive healthcare landscape.

財務健全性

The company generated $4,215 in revenue over the trailing twelve months, yet reported a net loss of $-6,278,191, revealing a severe disconnect between top-line sales and bottom-line profitability. This substantial gap between revenue and net income indicates an extremely fragile cost structure where operating expenses, likely including research and development or regulatory costs, vastly exceed gross revenues. The entity also posted an EBITDA of $-3,085,025 and a free cash flow of $-670,666, signaling ongoing cash burn that severely limits financial flexibility and the ability to fund operations without external capital. Margin analysis shows a gross margin of 55.6%, which suggests a favorable product pricing power or high gross efficiency at the manufacturing level, but this is entirely offset by an operating margin of -326658.1% and a profit margin of 0.0%, demonstrating that operating expenses are disproportionately high relative to sales volume. On the balance sheet, the company holds $2.19M in cash against a debt level of $58,650, resulting in a debt-to-equity ratio of 2.80 which technically classifies the firm as leveraged, though the debt amount is nominal compared to cash reserves. The current ratio stands at 13.16, indicating an exceptionally strong position in short-term liquidity where current assets significantly outweigh current liabilities. However, the return on equity is -217.1% and the return on assets is -68.2%, metrics that reveal management has yet to generate value from the shareholders' equity or the asset base, reflecting a period of significant financial distress or heavy investment loss.

バリュエーション評価

The trailing P/E ratio and forward P/E ratio are both listed as N/A due to the company's negative earnings and lack of positive expected earnings trajectory, which renders traditional earnings-based valuation multiples inapplicable. The price-to-book ratio is 8.24, indicating that the market is valuing the company at a significant premium over its book value, a phenomenon often seen in speculative micro-cap stocks or companies with substantial intangible assets not reflected on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 4090.68 and an EV/EBITDA of -3.99 suggest that investors are pricing the stock based on potential future recovery or asset liquidation value rather than current operational performance. The stock has traded between a 52-week high of $1.65 and a 52-week low of $0.71, placing the current market price within a highly volatile range that reflects significant uncertainty regarding the company's future prospects. The beta value is listed as N/A, which means that historical volatility data is insufficient to determine the stock's sensitivity to broader market movements, adding another layer of risk assessment complexity for analysts. These valuation discrepancies highlight a market that is pricing in high-risk characteristics rather than current financial stability.

Growth & Income

The revenue growth year-over-year is -9.7%, while earnings growth is N/A due to the absence of positive prior year earnings for comparison, indicating a contraction in sales volume rather than a decline in profitability rates. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, the firm is not distributing cash to shareholders but is instead retaining all earnings to attempt to fund its own growth or operational restructuring. The combination of negative revenue growth and zero dividend yield portrays a company that is currently unable to sustain organic expansion or provide income generation to its investor base. Overall, the growth and income profile for Caring Brands, Inc. is characterized by negative sales momentum and a complete lack of income distribution, presenting a challenging outlook for capital appreciation and shareholder returns in the near term.